This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Hypopharynx
CD2_BENIGN_HYPOPHARYNX_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum hypopharyngis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Hypopharynx
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Hypopharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 159 | 61 | 98 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.04 |
| Median age at first event (years) | 58.38 | 49.61 | 63.83 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 140
- Matched controls
- 1400
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.7
ICD-10 Finland
Benign neoplasm: Hypopharynx
+∞
155.9
119
*
UJC01
NOMESCO Finland
Scopy of lower throat
233.2
48.2
47
*
130
Kela drug reimbursment
Malignant tumour
+∞
36.0
33
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
29.2
27
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
120.9
27.8
29
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
86.6
25.9
28
*
C13.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of hypopharynx
+∞
17.0
16
*
2108A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Hypopharynx
+∞
17.0
16
*
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
96.1
15.9
17
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
15.9
15
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
40.9
14.8
18
5
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
166.7
14.8
15
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
9.0
13.9
30
41
A03FA01
ATC
metoclopramide; systemic, rectal
6.6
13.8
38
75
UDQ22
NOMESCO Finland
Microlaryngoscopy
44.7
13.5
16
*
H02AB02
ATC
dexamethasone; systemic
55.5
13.1
15
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
7.5
12.8
31
51
8070/3-C13.9
ICD-O-3
Squamous cell carcinoma, NOS, of hypopharynx, NOS
+∞
11.6
11
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
11.6
11
*
GBB00
NOMESCO Finland
Tracheostomy
38.5
11.5
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
11.2
60
232
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
118.5
10.6
11
*
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
+∞
10.5
10
*
R07.0
ICD-10 Finland
Pain in throat
9.3
10.3
21
26
N02AA05
ATC
oxycodone; systemic
5.1
10.1
33
79
ZXE00
NOMESCO Finland
One hour or less
3.2
9.8
77
388
Z51.5
ICD-10 Finland
Palliative care
23.7
9.5
13
6
ENA10
NOMESCO Finland
Biopsy of pharynx
+∞
9.5
9
*
C12
ICD-10 Finland
Malignant neoplasm of piriform sinus
+∞
9.5
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.4
9.1
52
207
R4190
NOMESCO Finland
Nutritional therapy
12.8
8.8
15
13
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
95.6
8.5
9
*
A04AA02
ATC
granisetron; systemic, transdermal
95.6
8.5
9
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
8.4
8
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.9
8.2
20
33
ZXC10
NOMESCO Finland
Use of laser
10.3
8.0
15
16
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
16.2
7.9
12
8
A04AA01
ATC
ondansetron; systemic, rectal
12.9
7.8
13
11
WX402
NOMESCO Finland
General anaesthesia
3.8
7.7
34
108
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
84.4
7.5
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.7
7.5
69
366
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
7.3
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.3
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.3
7
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
+∞
7.3
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
7.3
7
*
UDQ02
NOMESCO Finland
Direct laryngoscopy
31.8
7.2
9
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
5.9
7.1
19
36
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.6
7.0
24
60
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
42.2
6.8
8
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.8
6.8
51
236
UJC02
NOMESCO Finland
Rigid oesophagoscopy
23.9
6.8
9
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.8
6.7
16
26
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.8
6.7
12
12
A02BC05
ATC
esomeprazole; systemic
2.6
6.7
70
393
R13
ICD-10 Finland
Dysphagia
4.9
6.6
21
49
C61
ICD-10 Finland
Malignant neoplasm of prostate
73.0
6.5
7
*
DQA10
NOMESCO Finland
Biopsy of larynx
73.0
6.5
7
*
JN4BD
NOMESCO Finland
Extensive body CT
6.3
6.4
16
28
XX3DW
NOMESCO Finland
Time consuming IT work
5.4
6.3
18
37
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
6.3
6
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
6.3
6
*
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
+∞
6.3
6
*
R04.2
ICD-10 Finland
Haemoptysis
9.3
6.2
12
14
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
6.2
38
154
ZXA00
NOMESCO Finland
Right side
2.7
6.1
49
233
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
39
39
12.93
35.99
1.4
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
89
373
4.15
17.76
2.8
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
72
295
3.63
14.17
5.9
3.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
74
332
3.30
12.25
5.4
2.9
ph
7.4
7.4
—
10
56
(40758558) Short blood count panel - Blood
63
259
3.37
12.00
8.8
4.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
103
571
3.28
11.73
10.8
5.3
mmol/l
1.2
1.2
1.12
94
497
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
84
416
3.16
11.60
4.4
2.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
53
200
3.48
11.52
2.8
2.4
e6/l
1.1
1.0
0.09
29
116
(3013650) Neutrophils [#/volume] in Blood by Automated count
113
668
3.39
11.42
13.9
6.0
e9/l
4.2
4.1
0.18
105
586
(3007853) Bacteria identified in Skin by Aerobe culture
41
133
3.81
11.16
1.9
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
105
600
3.21
11.14
7.0
4.9
e9/l
1.7
1.8
0.81
93
528
(36304419) Bacteria [Presence] in Urine
68
304
3.16
11.12
3.7
2.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
70
320
3.12
10.99
3.8
2.6
e6/l
0.4
0.4
0.02
58
239
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
49
182
3.45
10.85
3.0
2.6
e6/l
2.1
2.1
0.02
25
98
(3002030) Lymphocytes/100 leukocytes in Blood
99
556
3.07
10.66
6.7
5.1
%
24.2
28.1
2.92
92
510
(3006315) Basophils [#/volume] in Blood
103
592
3.10
10.63
6.8
4.9
e9/l
0.0
0.0
0.22
88
514
(3002582) Erythrocytes [#/volume] in Urine
74
355
3.03
10.59
3.8
2.7
e6/l
58.5
40.5
0.16
62
272
(3018095) Leukocytes [#/volume] in Urine
82
417
3.00
10.55
4.3
3.0
e6/l
55.2
148.4
0.61
63
294
(3022096) Basophils/100 leukocytes in Blood
95
526
3.00
10.42
6.7
4.9
%
0.6
0.7
0.59
87
487
(3006504) Eosinophils/100 leukocytes in Blood
97
544
3.01
10.38
6.6
4.9
%
2.9
3.0
0.12
90
502
(3001604) Monocytes [#/volume] in Blood
102
589
3.04
10.33
6.9
4.9
e9/l
0.6
0.6
0.21
87
507
(3019069) Monocytes/100 leukocytes in Blood
97
548
2.97
10.17
6.7
5.2
%
8.6
8.7
0.09
90
506
(42870588) Differential panel, method unspecified - Blood
76
379
2.93
10.01
7.0
4.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
74
364
2.93
10.00
5.0
1.9
mmol/l
2.3
2.4
0.60
65
309
(3018010) Neutrophils/100 leukocytes in Blood
97
554
2.93
9.87
6.5
4.9
%
61.4
56.8
3.25
89
512
(3024561) Albumin [Mass/volume] in Serum or Plasma
90
505
2.80
9.29
7.4
3.1
g/l
33.5
36.1
3.77
81
474
(3044640) Blood type and Crossmatch panel - Blood
67
324
2.85
9.19
3.2
2.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
102
619
2.81
8.91
7.3
4.8
e9/l
0.2
0.2
0.42
90
546
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
16
8.03
8.53
1.4
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
31
102
3.53
8.12
4.4
2.9
u/l
257.9
238.8
0.23
31
95
(3002256) Pathology report gross observation
29
93
3.59
7.88
1.3
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
88
529
2.49
7.34
13.3
7.9
e9/l
0.0
0.0
0.00
72
436
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
86
513
2.47
7.28
4.7
3.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
53
256
2.61
6.99
2.9
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
41
174
2.83
6.96
2.2
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
21
60
3.88
6.70
2.0
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
79
471
2.35
6.48
11.4
9.9
inr
1.5
1.3
0.17
19
133
(3000850) Epithelial cells [#/volume] in Urine
49
237
2.54
6.38
2.9
2.0
e6/l
4.1
4.0
0.03
43
206
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
128
949
2.79
6.38
12.4
5.1
u/l
86.1
74.7
1.30
123
874
(3026782) Osmolality of Urine
47
224
2.56
6.30
3.5
2.2
mosm/kgh2o
508.4
556.7
0.87
40
186
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
30
114
3.01
6.16
2.1
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
113
2.92
5.69
2.0
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
12
25
5.11
5.59
1.8
2.8
%
219.6
191.4
0.61
12
25
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
34
4.42
5.48
2.3
2.3
u/ml
0.3
0.4
—
9
20
(3037467) Urinalysis macro (dipstick) panel - Urine
114
829
2.33
5.45
5.3
3.8
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
12
27
4.73
5.13
1.6
3.0
g/l
5.0
4.4
0.39
12
27
(3027945) Reticulocytes/100 erythrocytes in Blood
31
133
2.65
5.06
2.6
2.0
%
1.8
1.7
0.23
26
119
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
50
268
2.26
5.05
1.5
1.8
mg/l
1.2
1.0
0.45
45
210
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
43
220
2.31
4.82
3.2
1.9
mmol/l
2.5
2.4
1.02
38
183
(3000494) Fungus identified in Specimen by Culture
32
143
2.55
4.81
1.5
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
25
101
2.75
4.57
3.0
2.2
e9/l
71.6
67.0
0.17
13
80
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
29
127
2.57
4.53
4.2
2.5
%
26.6
25.3
0.12
29
112
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
49
275
2.13
4.34
1.9
1.9
mg/l
2.8
3.0
0.23
41
230
(3000991) Gas panel - Venous blood
24
98
2.71
4.29
13.2
8.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
78
523
1.96
4.21
2.0
1.9
pmol/l
86.7
93.1
0.52
41
285
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
120
937
2.14
4.17
5.3
3.7
pmol/l
14.7
14.8
0.17
112
848
(3011397) Hemoglobin [Presence] in Urine by Test strip
47
266
2.09
4.05
3.6
3.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
71
2.90
3.99
1.6
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
15
6.29
3.87
1.4
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
56
345
1.96
3.78
3.2
2.3
umol/l
7605.4
7621.8
0.00
49
299
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
99
2.55
3.71
3.0
1.8
ml/min/173m2
63.0
62.7
—
9
42
(3021440) Promyelocytes/100 leukocytes in Blood
19
74
2.78
3.71
5.2
5.2
%
0.0
0.1
—
5
16
(3004588) Protein electrophoresis panel - Serum or Plasma
19
74
2.78
3.71
1.4
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
32
163
2.21
3.56
4.2
2.2
umol/l
13.7
14.3
0.16
32
148
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
13
6.41
3.54
1.3
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
53
327
1.93
3.53
3.5
2.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
146
1266
2.87
3.52
28.0
11.0
mg/l
29.2
20.4
2.64
129
974
(3042936) Bacteria identified in Isolate by Culture
31
158
2.20
3.44
2.3
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
19
78
2.63
3.36
5.2
5.1
%
1.6
0.9
—
5
18
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
136
1162
2.18
3.06
6.2
4.5
mu/l
2.0
2.0
0.08
128
1058
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
22
4.27
2.93
1.8
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
13
5.58
2.90
1.3
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
26
133
2.14
2.86
13.3
7.2
mmol/l
2.0
1.3
0.47
20
105
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
10
6.18
2.72
1.2
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
24
3.91
2.71
1.6
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
20
96
2.24
2.56
1.8
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
29
162
1.97
2.53
1.5
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
57
2.60
2.53
1.5
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
16
4.52
2.50
1.0
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
34
3.07
2.46
2.1
2.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
12
5.15
2.42
1.0
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
79
599
1.63
2.40
6.5
4.7
estimate
0.0
0.0
0.00
16
104
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
42
269
1.76
2.40
3.8
3.8
ng/l
57.5
165.2
0.97
35
212
(3009261) Glucose [Presence] in Urine by Test strip
80
609
1.63
2.39
4.7
3.4
estimate
0.0
0.0
0.00
14
99
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
31
181
1.89
2.37
1.5
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
92
730
1.62
2.29
2.7
2.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
138
1221
1.99
2.28
25.0
10.4
ml/min/173m2
80.2
78.9
0.27
122
994
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
42
2.74
2.23
1.2
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
78
600
1.59
2.17
4.5
3.4
estimate
0.0
0.0
0.00
16
105
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
14
4.41
2.17
1.3
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
10
5.12
2.08
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
58
2.35
1.97
4.5
4.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
53
381
1.59
1.92
5.7
1.9
u/l
46.0
59.8
3.36
48
357
(3013707) Erythrocyte sedimentation rate by Westergren method
111
943
1.59
1.90
5.4
3.8
mm/h
14.3
10.3
1.60
105
860
(3021901) Oxygen saturation in Capillary blood
7
22
3.28
1.90
3.3
2.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
116
1.93
1.89
6.9
3.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
28
2.95
1.89
4.5
2.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
64
484
1.54
1.85
3.6
2.5
ug/l
183.0
127.7
1.18
59
443
(3044941) Cell count panel - Synovial fluid
5
12
4.26
1.83
1.2
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
12
4.26
1.83
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
60
2.27
1.83
1.3
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
35
2.66
1.83
1.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
21
118
1.90
1.81
1.8
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
25
150
1.79
1.76
1.9
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
13
3.93
1.73
1.2
1.0
—
—
—
0
0
(3000492) Spirometry study
21
120
1.86
1.72
1.2
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
19
3.24
1.67
4.5
2.1
e9/l
2.8
5.1
—
6
19
(3025941) Bacteria identified in Stool by Culture
13
63
2.16
1.65
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
102
865
1.50
1.64
4.0
3.0
u/l
75.1
46.4
1.55
94
817
(40760888) Immunoglobulin light chains.free panel - Serum
5
14
3.65
1.63
1.6
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
128
1142
1.62
1.61
29.1
12.2
%
38.0
40.8
2.30
100
817
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
20
3.08
1.59
4.7
3.1
%
54.2
57.5
—
6
20
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
13
64
2.12
1.59
14.8
7.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
34
230
1.61
1.56
1.7
1.7
nmol/l
1014.5
1261.0
0.79
22
182
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
15
3.41
1.53
1.4
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
21
2.93
1.52
1.8
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
21
2.93
1.52
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
16
3.19
1.45
1.8
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
16
3.19
1.45
1.8
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
22
2.79
1.45
1.0
1.1
—
—
—
0
0
(3015736) pH of Urine
60
469
1.45
1.41
4.0
3.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
7
29
2.48
1.41
4.6
3.2
mmol/l
24.6
25.2
—
7
24
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
23
2.67
1.38
1.8
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
17
3.00
1.37
1.2
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
106
924
1.44
1.35
5.0
3.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
18
2.83
1.29
1.0
2.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
18
2.83
1.29
1.0
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
5
18
2.83
1.29
1.4
2.9
nmol/l
0.5
1.1
—
5
11
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
35
2.35
1.29
1.9
3.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
15
85
1.84
1.28
5.2
4.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
55
433
1.41
1.22
5.0
3.1
mmol/l
7.2
8.1
0.76
47
356
(3020682) Albumin/Creatinine [Ratio] in Urine
56
443
1.41
1.21
6.9
4.0
mg/mmol
27.6
8.7
0.68
39
281
(40761511) CBC panel - Blood by Automated count
144
1347
1.73
1.21
21.7
10.8
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
12
66
1.88
1.12
3.9
2.2
%
0.8
0.6
0.86
12
66
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
31
2.31
1.12
1.1
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
146
1376
1.75
1.11
31.1
13.3
umol/l
84.4
80.5
0.39
146
1376
(3012516) Albumin [Mass/volume] in Urine
52
417
1.37
1.02
4.9
3.2
mg/l
234.8
58.7
0.52
36
270
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
49
1.89
1.00
1.7
1.6
—
—
—
0
0
(3020891) Body temperature
9
50
1.85
0.98
4.8
4.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
70
1.77
0.95
3.9
2.1
%
2.4
1.3
0.84
12
70
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
43
338
1.37
0.95
2.5
2.6
ug/l
0.8
0.8
0.05
32
219
(40760892) CBC W Ordered Manual Differential panel - Blood
34
258
1.40
0.92
8.0
4.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
61
509
1.32
0.91
4.3
3.6
ng/l
32.5
40.4
0.30
47
357
(3003694) ABO and Rh group [Type] in Blood
37
286
1.38
0.90
1.3
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
115
0.50
0.86
1.8
1.7
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
31
1.97
0.85
1.5
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
99
1.57
0.79
4.1
2.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
49
405
1.30
0.77
2.5
3.1
ng/l
2261.2
1079.2
0.70
42
332
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
53
1.74
0.77
2.6
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
39
312
1.33
0.77
5.7
3.5
estimate
0.0
0.0
0.00
14
100
(3013512) EKG study
48
396
1.30
0.76
5.5
3.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
24
2.12
0.75
1.4
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
133
1253
1.38
0.74
8.0
6.1
mmol/mol
43.4
40.2
1.91
126
1171
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
26
1.95
0.71
1.0
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
26
1.95
0.71
1.0
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
26
1.95
0.71
2.4
1.3
—
—
—
0
0
(4094501)
7
43
1.66
0.67
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
28
1.81
0.66
2.0
2.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
29
1.75
0.64
6.2
2.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
29
1.75
0.64
1.6
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
41
488
0.78
0.63
3.7
2.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
211
1.34
0.62
1.3
1.2
iu/ml
33.1
40.5
—
7
65
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
50
1.63
0.62
2.0
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
5
30
1.69
0.62
1.2
1.6
—
8.6
—
0
9
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
97
1.49
0.61
1.6
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
14
97
1.49
0.61
7.7
3.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
89
1.50
0.60
1.2
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
149
0.65
0.60
1.7
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
23
0.00
0.59
0.0
1.2
—
7.6
—
0
13
(40768443) Skin Pathology biopsy report
8
55
1.48
0.57
1.4
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
17
126
1.39
0.54
1.2
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
93
0.63
0.43
1.3
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
32
1.58
0.42
2.8
3.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
33
1.53
0.41
1.6
1.3
—
2.7
—
0
8
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
35
1.44
0.39
2.0
2.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
35
1.44
0.39
1.6
1.3
—
3.0
—
0
9
(3019832) Treponema pallidum Ab [Presence] in Serum
10
72
1.41
0.38
1.9
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
138
1336
1.25
0.37
5.3
5.3
mmol/l
2.7
2.7
0.14
129
1236
(21494755) Public health laboratory ask at order entry panel
9
122
0.72
0.37
1.1
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
41
363
1.17
0.34
1.6
1.7
mmol/l
1.5
1.3
0.92
36
312
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
52
478
1.13
0.26
5.7
3.6
—
—
—
0
0
(3019225) pH of Specimen
13
105
1.26
0.25
8.3
3.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
37
1.36
0.24
2.4
1.5
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
11
0.00
0.21
0.0
3.2
—
14.0
—
0
11
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
94.4
—
0
5
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
129
1259
1.13
0.20
4.1
4.2
mmol/l
1.3
1.3
0.34
117
1163
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
131
1280
1.13
0.19
5.4
4.7
mmol/l
6.3
6.0
1.05
125
1168
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
133
1301
1.14
0.19
4.5
4.7
mmol/l
1.3
1.4
2.62
124
1207
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
68
1.19
0.17
2.1
2.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
64
610
1.08
0.15
4.3
3.8
ug/l
2.0
2.0
0.02
58
551
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
133
1306
1.11
0.15
4.6
4.7
mmol/l
4.5
4.6
0.61
124
1217
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
18
160
1.14
0.14
9.7
7.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
51
486
1.07
0.12
4.1
3.6
%
26.1
24.3
0.26
26
224
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
86
1.17
0.11
1.8
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
46
1.09
0.09
3.6
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
53
1.14
0.09
1.3
1.3
—
—
—
0
0
(4034850)
5
62
0.80
0.08
8.6
11.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
73
1.10
0.07
3.9
3.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
36
344
1.06
0.07
5.3
3.2
—
—
—
0
0
(4010399)
10
97
1.03
0.00
1.2
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
24
235
1.03
0.00
2.4
1.3
g/l
2.2
2.7
0.57
14
135
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
132
0.98
0.00
1.5
1.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
32.0
—
0
6
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
85
0.94
0.00
1.3
1.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
1.7
—
0
9
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
6
0.00
0.00
0.0
1.2
—
9.2
—
0
6
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
6
0.00
0.00
0.0
1.0
—
92.7
—
0
6
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.2
—
9.3
—
0
6
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
6.0
—
0
6
(4211845)
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.1
—
131.2
—
0
9
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(44813793)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
13.3
—
0
5
(1002224) Polysomnography panel
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
8
0.00
0.00
0.0
2.0
—
1.9
—
0
8
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
27
270
1.00
0.00
1.3
1.3
u/ml
1.1
1.6
—
6
79
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
7.7
—
1194.0
—
0
7
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
8.3
—
1581.9
—
0
7
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
0.3
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
8.0
—
26.7
—
0
5
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
10.1
—
0
7
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
7.0
—
0.6
—
0
7
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
61
0.98
0.00
5.8
3.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
59
1.02
0.00
1.2
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
53
0.94
0.00
1.4
2.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_HYPOPHARYNX_EXALLC – Benign neoplasm: Hypopharynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).